Skip to Content
Severe eczema holding you back? Find the right treatment

Amphotericin b Pregnancy and Breastfeeding Warnings

Amphotericin b is also known as: Amphocin, Fungizone, Fungizone For Tissue Culture

Amphotericin b Pregnancy Warnings

Animal studies showed no evidence of fetal harm, however one animal model showed a higher rate of spontaneous abortions. There are no controlled data in human pregnancy. This drug crosses the placenta, with cord blood to maternal serum ratios ranging from 0.38 to 1. A small number of systemic fungal infections have been successfully treated with the injectable form of this medication without obvious fetal effects. AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B3 US FDA pregnancy category: B

See references

Amphotericin b Breastfeeding Warnings

Safety has not been established; benefit to mother should outweigh risk to the infant. Excreted into human milk: Unknown Excreted into animal milk: Data not available Comments: -Excretion into milk is possible. -Although gastrointestinal absorption is considered insignificant, use the oral formulations with caution in nursing women. -It may be prudent to advise women to stop breastfeeding while on this drug.

See references

References for pregnancy information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. Briggs GG, Freeman RK. "Drugs in Pregnancy and Lactation. 10th ed." Philadelphia, PA: Wolters Kluwer Health (2015):
  4. "Product Information. Amphotericin B (amphotericin B)." X-Gen Pharmaceuticals Inc, Big Flats, NY.

References for breastfeeding information

  1. Cerner Multum, Inc. "Australian Product Information." O 0
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. "Product Information. Amphotericin B (amphotericin B)." X-Gen Pharmaceuticals Inc, Big Flats, NY.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide